全文获取类型
收费全文 | 23726篇 |
免费 | 2106篇 |
国内免费 | 2310篇 |
出版年
2024年 | 30篇 |
2023年 | 191篇 |
2022年 | 413篇 |
2021年 | 735篇 |
2020年 | 610篇 |
2019年 | 709篇 |
2018年 | 719篇 |
2017年 | 613篇 |
2016年 | 819篇 |
2015年 | 1331篇 |
2014年 | 1528篇 |
2013年 | 1689篇 |
2012年 | 2119篇 |
2011年 | 1855篇 |
2010年 | 1304篇 |
2009年 | 1234篇 |
2008年 | 1494篇 |
2007年 | 1376篇 |
2006年 | 1296篇 |
2005年 | 1210篇 |
2004年 | 1100篇 |
2003年 | 1006篇 |
2002年 | 851篇 |
2001年 | 603篇 |
2000年 | 498篇 |
1999年 | 464篇 |
1998年 | 291篇 |
1997年 | 232篇 |
1996年 | 208篇 |
1995年 | 184篇 |
1994年 | 163篇 |
1993年 | 119篇 |
1992年 | 158篇 |
1991年 | 128篇 |
1990年 | 103篇 |
1989年 | 107篇 |
1988年 | 72篇 |
1987年 | 82篇 |
1986年 | 74篇 |
1985年 | 38篇 |
1984年 | 30篇 |
1983年 | 47篇 |
1982年 | 20篇 |
1981年 | 22篇 |
1980年 | 19篇 |
1979年 | 29篇 |
1978年 | 20篇 |
1977年 | 24篇 |
1973年 | 20篇 |
1970年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 576 毫秒
991.
该文旨在探讨干扰素-β(interferon-β,IFN-β)在肺炎链球菌(Streptococcus pneumoniae,S.pn)感染早期对宿主炎症免疫的影响.使用外源重组IFN-β蛋白(recombinant IFN-β,rIFN-β)预处理WT小鼠及其腹腔渗出巨噬细胞(peritoneal exudate m... 相似文献
992.
993.
994.
995.
Wi-Sun Ryu Keun-Sik Hong Sang-Wuk Jeong Jung E. Park Beom Joon Kim Joon-Tae Kim Kyung Bok Lee Tai Hwan Park Sang-Soon Park Jong-Moo Park Kyusik Kang Yong-Jin Cho Hong-Kyun Park Byung-Chul Lee Kyung-Ho Yu Mi Sun Oh Soo Joo Lee Jae Guk Kim Jae-Kwan Cha Dae-Hyun Kim Jun Lee Moon-Ku Han Man Seok Park Kang-Ho Choi Juneyoung Lee Jeffrey L. Saver Eng H. Lo Hee-Joon Bae Dong-Eog Kim 《PLoS medicine》2022,19(2)
BackgroundPreclinical data suggest circadian variation in ischemic stroke progression, with more active cell death and infarct growth in rodent models with inactive phase (daytime) than active phase (nighttime) stroke onset. We aimed to examine the association of stroke onset time with presenting severity, early neurological deterioration (END), and long-term functional outcome in human ischemic stroke.Methods and findingsIn a Korean nationwide multicenter observational cohort study from May 2011 to July 2020, we assessed circadian effects on initial stroke severity (National Institutes of Health Stroke Scale [NIHSS] score at admission), END, and favorable functional outcome (3-month modified Rankin Scale [mRS] score 0 to 2 versus 3 to 6). We included 17,461 consecutive patients with witnessed ischemic stroke within 6 hours of onset. Stroke onset time was divided into 2 groups (day-onset [06:00 to 18:00] versus night-onset [18:00 to 06:00]) and into 6 groups by 4-hour intervals. We used mixed-effects ordered or logistic regression models while accounting for clustering by hospitals. Mean age was 66.9 (SD 13.4) years, and 6,900 (39.5%) were women. END occurred in 2,219 (12.7%) patients. After adjusting for covariates including age, sex, previous stroke, prestroke mRS score, admission NIHSS score, hypertension, diabetes, hyperlipidemia, smoking, atrial fibrillation, prestroke antiplatelet use, prestroke statin use, revascularization, season of stroke onset, and time from onset to hospital arrival, night-onset stroke was more prone to END (adjusted incidence 14.4% versus 12.8%, p = 0.006) and had a lower likelihood of favorable outcome (adjusted odds ratio, 0.88 [95% CI, 0.79 to 0.98]; p = 0.03) compared with day-onset stroke. When stroke onset times were grouped by 4-hour intervals, a monotonic gradient in presenting NIHSS score was noted, rising from a nadir in 06:00 to 10:00 to a peak in 02:00 to 06:00. The 18:00 to 22:00 and 22:00 to 02:00 onset stroke patients were more likely to experience END than the 06:00 to 10:00 onset stroke patients. At 3 months, there was a monotonic gradient in the rate of favorable functional outcome, falling from a peak at 06:00 to 10:00 to a nadir at 22:00 to 02:00. Study limitations include the lack of information on sleep disorders and patient work/activity schedules.ConclusionsNight-onset strokes, compared with day-onset strokes, are associated with higher presenting neurologic severity, more frequent END, and worse 3-month functional outcome. These findings suggest that circadian time of onset is an important additional variable for inclusion in epidemiologic natural history studies and in treatment trials of neuroprotective and reperfusion agents for acute ischemic stroke.Wi-Sun Ryu and colleagues investigate the association of stroke onset time with presenting severity, early neurological deterioration (END), and long-term functional outcome in ischemic stroke. 相似文献
996.
997.
998.
Anti-phospholipase A2 receptor autoantibody (PLA2R-Ab) plays a critical role in the pathogenesis of primary membranous nephropathy (PMN), an autoimmune kidney disease characterized by immune deposits in the glomerular subepithelial spaces and proteinuria. However, the mechanism of how PLA2R-Abs interact with the conformational epitope(s) of PLA2R has remained elusive. PLA2R is a single transmembrane helix receptor containing ten extracellular domains that begin with a CysR domain followed by a FnII and eight CTLD domains. Here, we examined the interactions of PLA2R-Ab with the full PLA2R protein, N-terminal domain truncations, and C-terminal domain deletions under either denaturing or physiological conditions. Our data demonstrate that the PLA2R-Abs against the dominant epitope (the N-terminal CysR-CTLD1 triple domain) possess weak cross-reactivities to the C-terminal domains beyond CTLD1. Moreover, both the CysR and CTLD1 domains are required to form a conformational epitope for PLA2R-Ab interaction, with FnII serving as a linker domain. Upon close examination, we also observed that patients with newly diagnosed PMN carry two populations of PLA2R-Abs in sera that react to the denatured CysR-CTLD3 (the PLA2R-Ab1) and denatured CysR-CTLD1 (the PLA2R-Ab2) domain complexes on Western blots, respectively. Furthermore, the PLA2R-Ab1 appeared at an earlier time point than PLA2R-Ab2 in patients, whereas the increased levels of PLA2R-Ab2 coincided with the worsening of proteinuria. In summary, our data support that an integrated folding of the three PLA2R N-terminal domains, CysR, FnII, and CTLD1, is a prerequisite to forming the PLA2R conformational epitope and that the dominant epitope-reactive PLA2R-Ab2 plays a critical role in PMN clinical progression. 相似文献
999.
1000.
为了探究ASFV E248R蛋白调控cGAS-STING信号通路的机制,利用双荧光素酶报告系统验证ASFV E248R蛋白够剂量依赖性地抑制cGAS-STING和HT-DNA诱导的IFN-β的产生。通过相对定量PCR技术验证,过表达E248R抑制IFNB1、RANTES、IL-6和TNF-αβ基因的转录水平。免疫共沉淀和激光共聚焦试验结果表明,E248R与STING相互作用。通过蛋白印迹试验证实,过表达E248R可抑制STING的表达。研究表明ASFV E248R蛋白通过抑制STING的表达拮抗天然免疫应答。该结果将扩展对ASF免疫逃逸的认知,为疫苗的研制提供新的思路。 相似文献